Document is current
Any future updates will be listed below
-
Authors
Leick, Christian
Larsen, Lars Bruun
Larrabee Sonderlund, Anders
Svensson, Nanna Herning
Sondergaard, Jens
Thilsing, Trine
-
Funding
Funding for this research was provided by:
TrygFonden (125508, 125508, 125508, 125508, 125508, 125508)
The Committee of Quality and Education in General Practice in the Region of Southern Denmark (18/527, 18/527, 18/527, 18/527, 18/527, 18/527)
The Region of Southern Denmark (11/13244, 11/13244, 11/13244, 11/13244, 11/13244, 11/13244)
The Fund for General Practice (A2804, A2804, A2804, A2804, A2804, A2804)
- License Information
-
More Information
Article History
Received: 20 January 2022
Accepted: 4 May 2022
First Online: 13 May 2022
Declarations
:
: The study was approved by the Research & Innovation Organisation (RIO) at the University of Southern Denmark (18/32742), and the TOF pilot study 2 was registered at ClinicalTrial.gov (NCT03913585) (13). According to Danish regulations (Act on Research Ethics Review of Health Research Projects [Sect. 14.2]), this study did not need approval from a health research ethics committee as no research on human tissue or other biological material was performed. This was confirmed in writing by the Regional Committee on Health Research Ethics for Southern Denmark (J.nr. S-20152000–28).The study complies with the Helsinki declaration with informed written consent to study participation and to disclosure of data from the GPs EPR from all participants before enrolment. Participants were asked to read the information and electronically sign the consent form. Written information was supplemented with short videos describing the purpose of the study.
: Not applicable.
: The authors declare that they have no competing interests.
